[HTML][HTML] Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri, F Correard… - Pharmaceuticals, 2022 - mdpi.com
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri… - …, 2022 - search.proquest.com
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
[HTML][HTML] Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri, F Correard… - …, 2022 - ncbi.nlm.nih.gov
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri… - Pharmaceuticals …, 2022 - pubmed.ncbi.nlm.nih.gov
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri, F Correard… - …, 2022 - hal.umontpellier.fr
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives.
V Montero, M Montana, O Khoumeri… - Pharmaceuticals …, 2022 - search.ebscohost.com
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives.
V Montero, M Montana, O Khoumeri… - Pharmaceuticals …, 2022 - europepmc.org
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri, F Correard… - …, 2022 - amu.hal.science
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
V Montero, M Montana, O Khoumeri, F Correard… - …, 2022 - hal.science
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
[PDF][PDF] Synthesis
V Montero, M Montana, O Khoumeri… - … Activity, and In Silico …, 2022 - hal.science
The quinoxaline core is a promising scaffold in medicinal chemistry. Multiple quinoxaline
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …
derivatives, such as the topoisomerase IIβ inhibitor XK-469 and the tissue transglutaminase …